Inhibition of Src Kinase Blocks High Glucose–Induced EGFR Transactivation and Collagen Synthesis in Mesangial Cells and Prevents Diabetic Nephropathy in Mice
暂无分享,去创建一个
Ling Xia | Abdul Momen | I. G. Fantus | E. Masson | H. Goldberg | A. Momen | E. Shikatani | M. Husain | R. John | Mansoor Husain | I. George Fantus | Rohan John | Kanta Taniguchi | Howard J. Goldberg | Ken W.K. Lee | Anu Shah | Laura Stavar | Elodie A.Y. Masson | Eric A. Shikatani | L. Xia | Kanta Taniguchi | Anu Shah | Laura Stavar | Ling Xia | K. Lee
[1] A. Ergul,et al. Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.
[2] Shunqiang Li,et al. Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach , 2005, Nature Medicine.
[3] J. Douglas,et al. Arachidonic acid induces ERK activation via Src SH2 domain association with the epidermal growth factor receptor. , 2006, Kidney international.
[4] M. Mauer,et al. The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007 , 2008, Diabetologia.
[5] S. Courtneidge,et al. The interplay between Src family kinases and receptor tyrosine kinases , 2004, Oncogene.
[6] T. Kita,et al. Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy , 2006, Laboratory Investigation.
[7] D. Stewart,et al. Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. , 2002, The Journal of clinical investigation.
[8] M. Moasser,et al. The epidermal growth factor receptor family: Biology driving targeted therapeutics , 2008, Cellular and Molecular Life Sciences.
[9] M. Kretzler,et al. From Fibrosis to Sclerosis , 2008, Diabetes.
[10] K. Ramana,et al. Aldose reductase regulates high glucose-induced ectodomain shedding of tumor necrosis factor (TNF)-alpha via protein kinase C-delta and TNF-alpha converting enzyme in vascular smooth muscle cells. , 2009, Endocrinology.
[11] Samy Suissa,et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes. , 2009, The New England journal of medicine.
[12] P. Fioretto,et al. The Kidney in Diabetes: Dynamic Pathways of Injury and Repair , 2007 .
[13] P. Johnston,et al. Src and ADAM-17-mediated shedding of transforming growth factor-alpha is a mechanism of acute resistance to TRAIL. , 2008, Cancer research.
[14] Hong Wang,et al. Mesangial cell NADPH oxidase upregulation in high glucose is protein kinase C dependent and required for collagen IV expression. , 2006, American journal of physiology. Renal physiology.
[15] Jia Yin,et al. ERK1/2 mediate wounding- and G-protein-coupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding. , 2009, Investigative ophthalmology & visual science.
[16] G. Striker,et al. Glomerular type IV collagen in patients with diabetic nephropathy with and without additional glomerular disease. , 2000, Kidney international.
[17] C. Betsholtz,et al. A new method for large scale isolation of kidney glomeruli from mice. , 2002, The American journal of pathology.
[18] A. Nishiyama,et al. BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions. , 2004, Kidney international.
[19] P. Xie,et al. Diabetic Nephropathy: Mechanisms of Renal Disease Progression , 2008, Experimental biology and medicine.
[20] A. Ullrich,et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF , 1999, Nature.
[21] M. Bissell,et al. Targeting TACE-dependent EGFR ligand shedding in breast cancer. , 2007, The Journal of clinical investigation.
[22] Y. Mori,et al. Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells. , 2001, Kidney International.
[23] C. Alpers,et al. Mouse models of diabetic nephropathy. , 2005, Journal of the American Society of Nephrology : JASN.
[24] M. Haneda,et al. J Am Soc Nephrol 14: 1374–1382, 2003 Overview of Glucose Signaling in Mesangial Cells in Diabetic Nephropathy , 2022 .
[25] M. Soellner,et al. Development of a highly selective c-Src kinase inhibitor. , 2012, ACS chemical biology.
[26] D. Threadgill,et al. EGFR signaling promotes TGFβ-dependent renal fibrosis. , 2012, Journal of the American Society of Nephrology : JASN.
[27] Craig E. Higgins,et al. TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling. , 2008, Journal of molecular and cellular cardiology.
[28] A. Eid,et al. Nox4 NAD(P)H Oxidase Mediates Src-dependent Tyrosine Phosphorylation of PDK-1 in Response to Angiotensin II , 2008, Journal of Biological Chemistry.
[29] D. Lawrence,et al. A PAI-1 mutant, PAI-1R, slows progression of diabetic nephropathy. , 2008, Journal of the American Society of Nephrology : JASN.
[30] N. Wahab,et al. J Am Soc Nephrol 14: 1358–1373, 2003 Extracellular Matrix Metabolism in Diabetic Nephropathy , 2022 .
[31] A. Ullrich,et al. Distinct ADAM Metalloproteinases Regulate G Protein-coupled Receptor-induced Cell Proliferation and Survival* , 2004, Journal of Biological Chemistry.
[32] J. Siegfried,et al. Src Family Kinases Mediate Epidermal Growth Factor Receptor Ligand Cleavage, Proliferation, and Invasion of Head and Neck Cancer Cells , 2004, Cancer Research.
[33] Ling Zhu,et al. TGF-beta-regulated collagen type I accumulation: role of Src-based signals. , 2007, American journal of physiology. Cell physiology.
[34] Y. Mori,et al. Involvement of HB-EGF and EGF receptor transactivation in TGF-beta-mediated fibronectin expression in mesangial cells. , 2002, Kidney international.
[35] M. Maa,et al. c-Src-mediated Phosphorylation of the Epidermal Growth Factor Receptor on Tyr845 and Tyr1101 Is Associated with Modulation of Receptor Function* , 1999, The Journal of Biological Chemistry.
[36] T. Kita,et al. Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy , 2006, Laboratory Investigation.
[37] G. Bokoch,et al. The involvement of the tyrosine kinase c-Src in the regulation of reactive oxygen species generation mediated by NADPH oxidase-1. , 2008, Molecular biology of the cell.
[38] Ling Zhu,et al. TGF-β-regulated collagen type I accumulation: role of Src-based signals , 2007 .
[39] Eva Klinman,et al. Ectodomain cleavage of the EGF ligands HB‐EGF, neuregulin1‐β, and TGF‐α is specifically triggered by different stimuli and involves different PKC isoenzymes , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[40] B. H. Shah,et al. Roles of Src and Epidermal Growth Factor Receptor Transactivation in Transient and Sustained ERK1/2 Responses to Gonadotropin-releasing Hormone Receptor Activation* , 2003, Journal of Biological Chemistry.
[41] L. Luttrell,et al. 5-HT2A Receptor Induces ERK Phosphorylation and Proliferation through ADAM-17 Tumor Necrosis Factor-α-converting Enzyme (TACE) Activation and Heparin-bound Epidermal Growth Factor-like Growth Factor (HB-EGF) Shedding in Mesangial Cells* , 2006, Journal of Biological Chemistry.
[42] H. Wiley,et al. Multiple Mechanisms Are Responsible for Transactivation of the Epidermal Growth Factor Receptor in Mammary Epithelial Cells* , 2008, Journal of Biological Chemistry.
[43] Timothy J. Yeatman,et al. A renaissance for SRC , 2004, Nature Reviews Cancer.
[44] Carlos L. Arteaga,et al. Transforming Growth Factor (cid:2) Engages TACE and ErbB3 To Activate Phosphatidylinositol-3 Kinase/Akt in ErbB2-Overexpressing Breast Cancer and Desensitizes Cells to Trastuzumab (cid:1) † , 2008 .
[45] Weina Yang,et al. Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats. , 2012, Cytokine.
[46] J. Krepinsky,et al. Collagen I induction by high glucose levels is mediated by epidermal growth factor receptor and phosphoinositide 3-kinase/Akt signalling in mesangial cells , 2007, Diabetologia.
[47] M G Natchus,et al. Discovery of potent, achiral matrix metalloproteinase inhibitors. , 1998, Journal of medicinal chemistry.
[48] G. Mills,et al. Phosphorylation of TNF-alpha converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[49] S. Kumar,et al. HB-EGF release mediates glucose-induced activation of the epidermal growth factor receptor in mesangial cells. , 2011, American journal of physiology. Renal physiology.
[50] J. Hanke,et al. Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor , 1996, The Journal of Biological Chemistry.
[51] M. Gishizky,et al. SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling , 2000, Molecular and Cellular Biology.
[52] M. Breyer. Stacking the deck for drug discovery in diabetic nephropathy: in search of an animal model. , 2008, Journal of the American Society of Nephrology : JASN.
[53] G. Amorino,et al. Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway , 2007, Oncogene.
[54] G. Weskamp,et al. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands , 2004, The Journal of cell biology.
[55] J. Padbury,et al. A Novel Phosphoinositide 3-Kinase-dependent Pathway for Angiotensin II/AT-1 Receptor-mediated Induction of Collagen Synthesis in MES-13 Mesangial Cells* , 2007, Journal of Biological Chemistry.